In colorectal cancer, CsA inhibits tumor growth as a result of lower levels of c-Myc, p21(WAF1/CIP1), and proliferating cell nuclear antigen (PCNA) (Masuo et al. 2009; Werneck et al. 2012). The gene discussed is PCNA; the disease is colorectal cancer.